Hsu RK, Sension MG, Fusco JS, Brunet L, Levis B, Cochran Q, Sridhar G, Vannappagari V, Brown K, van Wyk J, Wohlfeiler MB, Fusco GP. [Poster 527] Outcomes for Individuals who Initiate CAB+RPV LA in OPERA with Viral Loads ≥50 vs. <50 copies/mL. Conference on Retroviruses and Opportunistic Infections (CROI). Denver, CO; 2026
Research Category: Abstracts and Posters
[Poster 534] Body Mass Index and Virologic Outcomes in Individuals on CAB+RPV LA in the OPERA Cohort
Sension MG, Hsu RK, Fusco JS, Brunet L, Levis B, Cochran Q, Sridhar G, Vannappagari V, Brown K, van Wyk J, Wohlfeiler MB, Fusco GP. [Poster 534] Body Mass Index and Virologic Outcomes in Individuals on CAB+RPV LA in the OPERA Cohort. Conference on Retroviruses and Opportunistic Infections (CROI). Denver, CO; 2026
[Poster 980] Comparing PrEP coverage and HIV acquisition between CAB LA and oral PrEP in the OPERA cohort
Barnett S, Brunet L, Fusco JS, Mounzer K, Frost KR, Sarkar S, Brown K, Garges HP, Vannappagari V, Fusco GP. [Poster 980] Comparing PrEP coverage and HIV acquisition between CAB LA and oral PrEP in the OPERA cohort. Conference on Retroviruses and Opportunistic Infections (CROI). Denver, CO; 2026
[Poster 979] Cabotegravir LA for PrEP: Progress in HIV Prevention from Three Years of OPERA Data
Hsu RK, Brunet L, Mills A, Frost KR, Pierone G, Sension M, Lackey PC, Mounzer K, Wohlfeiler MB, Fusco JS, Aboud M, Budnik P, Guignard A, Vannappagari V, Fusco GP. [Poster 979] Cabotegravir LA for PrEP: Progress in HIV Prevention from Three Years of OPERA Data. Conference on Retroviruses and Opportunistic Infections (CROI). Denver, CO; 2026
[Poster 593] HIV-HBV Co-infection and Long-Acting Cabotegravir + Rilpivirine in the US: HBV and HIV Outcomes
Dieterich DT, Brunet L, Hsu RK, Mounzer K, Pierone G, Wohlfeiler MB, Weber RP, Fusco JS, Henegar C, Vannappagari V, Brown K, Payvandi N, Fusco GP. [Poster 593] HIV-HBV Co-infection and Long-Acting Cabotegravir + Rilpivirine in the US: HBV and HIV Outcomes. Conference on Retroviruses and Opportunistic Infections (CROI). Denver, CO; 2026
P-371 – Few differences in persistence and virologic outcomes across age groups among CAB+RPV LA users: Findings from the OPERA Cohort
Sension MG, Hsu RK, Fusco JS, Brunet L, Levis B, Cochran Q, Sridhar G, Vannappagari V, Van Wyk J, Wohlfeiler MB, Fusco GP. P-371 – Few differences in persistence and virologic outcomes across age groups among CAB+RPV LA users: Findings from the OPERA Cohort IDWeek. Atlanta, GA, USA; October 19-22, 2025
P-332 – Screening Practices for HIV and Sexually Transmitted Infections During Cabotegravir Long Acting or Daily Oral Pre-Exposure Prophylaxis Use in the US
Barnett S, Brunet L, Fusco J, Mounzer K, Frost K, Sarkar S, Brown K, Garges H, Vannappagari V, Fusco G. P-332 – Screening Practices for HIV and Sexually Transmitted Infections During Cabotegravir Long Acting or Daily Oral Pre-Exposure Prophylaxis Use in the US. IDWeek. Atlanta, GA, USA; October 19-22, 2025
Clinical Outcomes Among Women in the OPERA Cohort Initiating CAB+RPV LA with Viral Loads ≥ 50 copies/mL13th IAS Conference on HIV Science
Altamirano J, Levis B, Markarian C, Cochran Q, Sherman C, Toeque M-G, Armas L, Sridhar G, Vannappagari V, Brown K, Fusco JS. Clinical Outcomes Among Women in the OPERA Cohort Initiating CAB+RPV LA with Viral Loads ≥ 50 copies/mL13th IAS Conference on HIV Science. 13th International AIDS Society Conference on HIV Science (IAS). Kigali, Rwanda; July 13-17, 2025
Vaccinations Among Long-Acting Injectable Versus Daily Oral Antiretroviral Therapy Users in the OPERA Cohort
Lackey PC, Palmieri Weber R, Pierone GJ, Sension M, Mills A, Wohlfeiler MB, Fusco JS, Levis B, Sridhar G, Vannappagari V, van Wyk J, Fusco GP. Vaccinations Among Long-Acting Injectable Versus Daily Oral Antiretroviral Therapy Users in the OPERA Cohort. In: 20th International Conference on HIV Treatment and Prevention Adherence (Continuum). San Juan, PR, USA; June 10-12, 2025
Incident diagnoses of HIV on Oral and Long-Acting Pre-Exposure Prophylaxis in the OPERA Cohort
Barnett S, Brunet L, Fusco J, Mounzer K, Frost K, Levis B, Sarkar S, Brown K, Garges H, Vannappagari V, Fusco G. Incident diagnoses of HIV on Oral and Long-Acting Pre-Exposure Prophylaxis in the OPERA Cohort. In: ACTHIV. Chicago, IL, USA; May 1-3, 2025.